ArticleTherapeutic advances in neurological disorders2019

Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis.

Luca Prosperini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.